Hostname: page-component-8448b6f56d-cfpbc Total loading time: 0 Render date: 2024-04-18T15:36:02.379Z Has data issue: false hasContentIssue false

Evaluation of crestar for synchronising oestrus in maiden heifers used as embryo transfer recipients

Published online by Cambridge University Press:  24 November 2017

L D Tregaskes
Affiliation:
The Scottish Agricultural College, School of Agriculture, 581 King Street, Aberdeen AB9 1UD
P J Broadbent
Affiliation:
The Scottish Agricultural College, School of Agriculture, 581 King Street, Aberdeen AB9 1UD
D F Dolman
Affiliation:
The Scottish Agricultural College, School of Agriculture, 581 King Street, Aberdeen AB9 1UD
S P Grimmer
Affiliation:
The Scottish Agricultural College, School of Agriculture, 581 King Street, Aberdeen AB9 1UD
Get access

Extract

Progesterone or progestogens can be administered either intravaginally or via ear implants. The ear implant Synchromate B (SMB) has been used widely in the USA and Europe. SMB (Ceva laboratories) utilises a 6mg norgestomet ear implant with an intramuscular injection of 5mg oestradiol valerate and 3mg norgestomet. Crestar (Intervet, UK) is a similar regime but the ear implant contains 3mg norgestomet. The objective of this experiment was to evaluate the effectiveness of Crestar as a synchronising agent for potential recipients in an embryo transfer programme.

A total of 334 Hereford x British Friesian maiden heifers, housed in straw bedded pens were allocated at random to be synchronised using either a PRID (Sanofi) plus prostaglandin; or a Crestar (Intervet, UK) regime. Equal numbers of heifers received each treatment.

Type
Ruminant Reproduction
Copyright
Copyright © The British Society of Animal Production 1992

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)